Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 9/20 | 0.47 |
| ▸ | MMP9 | P14780 | 9/20 | 0.47 |
| ▸ | MMP14 | P50281 | 5/20 | 0.47 |
| ▸ | MMP3 | P08254 | 5/20 | 0.47 |
| ▸ | MMP8 | P22894 | 4/20 | 0.47 |
| ▸ | MMP7 | P09237 | 2/20 | 0.47 |
| ▸ | MMP1 | P03956 | 2/20 | 0.47 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.47 |
| ▸ | KDM1A | O60341 | 2/20 | 0.41 |
| ▸ | LTA4H | P09960 | 4/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | BAX | Q07812 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6862953 | 0.86 | MMP1 (0.31) | MMP2MMP9MMP14MMP3MMP8 | |
| SCHEMBL6864599 | 0.85 | MMP9 (0.47) | MMP2MMP9MMP14MMP3MMP8 | |
| SCHEMBL6865085 | 0.83 | KDM1A (0.36) | KDM1AMAOB | |
| SCHEMBL6861001 | 0.76 | MAPT (0.35) | KDM1AMAOB | |
| SCHEMBL6864830 | 0.76 | MAPT (0.33) | KDM1A | |
| SCHEMBL5209800 | 0.76 | — | — | |
| SCHEMBL6863277 | 0.75 | THRB (0.41) | MMP2MMP9MMP14MMP3MMP8 | |
| SCHEMBL5205366 | 0.74 | — | — | |
| SCHEMBL6862967 | 0.74 | MMP2 (0.40) | MMP2MMP9MMP14MMP3MMP8 | |
| SCHEMBL5204143 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6794471-B2 | OF A HYDROXYHYDROCARBYL- OR MERCAPTOHYDROCARBYL- DITHIOLANE; CURED OPTICAL ARTICLE FORMED BY PHOTOPOLYMERIZING THE ACRYLATE | MITSUI CHEMICALS, INC. (JP) | 2004-09-21 | — | — | US | disclosed |
| EP-1193264-B1 | Acrylic ester compound and usage thereof | MITSUI CHEMICALS INC (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-20020061995-A1 | Acrylic ester compound and usage thereof | MITSUI CHEMICALS, INC. (JP) | 2002-05-23 | — | — | US | disclosed |
| EP-1193264-A1 | Acrylic ester compound and usage thereof | Mitsui Chemicals, Inc. (JP) | 2002-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020061995-A1 | Acrylic ester compound and usage thereof | ASS1, HAT1, EIF2B1 | MMP2 4270/4885MMP9 4472/4885MMP14 4100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.